MRVL Stock Analysis: Marvell Technology | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 169.349m USD | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.59B
EPS Trend: 85.0%
Qual. Beats: 3
Rev. Trend: 88.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality
| Net Income: 2.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.67 > 1.0 |
| NWC/Revenue: 59.51% < 20% (prev 13.78%; Δ 45.72% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.06b > Net Income 2.53b |
| Net Debt (1.75b) to EBITDA (4.62b): 0.38 < 3 |
| Current Ratio: 3.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (893.3m) vs 12m ago 2.02% < -2% |
| Gross Margin: 50.64% > 18% (prev 43.17%; Δ 7.47% > 0.5%) |
| Asset Turnover: 37.12% > 50% (prev 32.47%; Δ 4.65% > 0%) |
| Interest Coverage Ratio: 15.80 > 6 (EBIT TTM 3.34b / Interest Expense TTM 211.2m) |
| A: 0.19 (Total Current Assets 7.46b - Total Current Liabilities 2.28b) / Total Assets 26.9b |
| B: 0.05 (Retained Earnings 1.34b / Total Assets 26.9b) |
| C: 0.14 (EBIT TTM 3.34b / Avg Total Assets 23.5b) |
| D: 2.09 (Book Value of Equity 18.2b / Total Liabilities 8.73b) |
| Altman-Z'' = 4.57 = AA |
| DSRI: 1.22 (Receivables 1.87b/1.14b, Revenue 8.72b/6.50b) |
| GMI: 0.85 (GM 43.17% / 50.64%) |
| AQI: 0.89 (AQ_t 0.68 / AQ_t-1 0.76) |
| SGI: 1.34 (Revenue 8.72b / 6.50b) |
| TATA: 0.02 (NI 2.53b - CFO 2.06b) / TA 26.9b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of July 21, 2026, the stock is trading at USD 194.94 with a total of 24,530,203 shares traded. Over the past week, the price has changed by +0.00%, over one month by +0.00%, over three months by +0.00% and over the past year by +0.00%.
Current recommended Stop Loss: 156.90 (which is 19.5% or 1.7 ATR below the current price).
Marvell Technology has received a consensus analysts rating of 4.49. Therefore, it is recommended to buy MRVL.
- StrongBuy: 23
- Buy: 9
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 253.7 | 30.1% |
P/E Trailing = 64.8385
P/E Forward = 46.5116
P/S = 19.4272
P/B = 9.2968
P/EG = 1.0663
Revenue TTM = 8.72b USD
EBIT TTM = 3.34b USD
EBITDA TTM = 4.62b USD
Long Term Debt = 4.96b USD (from longTermDebt, last quarter)
Short Term Debt = 54.5m USD (from shortTermDebt, last quarter)
Debt = 5.59b USD (from shortLongTermDebtTotal, last quarter) + Leases 315.9m
Net Debt = 1.75b USD (calculated: Debt 5.59b - CCE 3.84b)
Enterprise Value = 171b USD (169b + Debt 5.59b - CCE 3.84b)
Interest Coverage Ratio = 15.80 (Ebit TTM 3.34b / Interest Expense TTM 211.2m)
EV/FCF = 102.8x (Enterprise Value 171b / FCF TTM 1.66b)
FCF Yield = 0.97% (FCF TTM 1.66b / Enterprise Value 171b)
FCF Margin = 19.09% (FCF TTM 1.66b / Revenue TTM 8.72b)
Net Margin = 28.99% (Net Income TTM 2.53b / Revenue TTM 8.72b)
Gross Margin = 50.64% ((Revenue TTM 8.72b - Cost of Revenue TTM 4.30b) / Revenue TTM)
Gross Margin QoQ = 52.15% (prev 48.37%)
Tobins Q-Ratio = 6.35 (Enterprise Value 171b / Total Assets 26.9b)
Interest Expense / Debt = 3.78% (Interest Expense 211.2m / Debt 5.59b)
Taxrate = 13.29% (387.3m / 2.91b)
NOPAT = 2.89b (EBIT 3.34b * (1 - 13.29%))
Current Ratio = 3.28 (Total Current Assets 7.46b / Total Current Liabilities 2.28b)
Debt / Equity = 0.31 (Debt 5.59b / totalStockholderEquity, last quarter 18.2b)
Debt / EBITDA = 0.38 (Net Debt 1.75b / EBITDA 4.62b)
Debt / FCF = 1.05 (Net Debt 1.75b / FCF TTM 1.66b)
Total Stockholder Equity = 15.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.76% (Net Income 2.53b / Total Assets 26.9b)
RoE = 16.84% (Net Income TTM 2.53b / Total Stockholder Equity 15.0b)
RoCE = 16.72% (EBIT 3.34b / Capital Employed (Equity 15.0b + L.T.Debt 4.96b))
RoIC = 11.91% (NOPAT 2.89b / Invested Capital 24.3b)
WACC = 16.57% (E(169b)/V(175b) * Re(17.01%) + D(5.59b)/V(175b) * Rd(3.78%) * (1-Tc(0.13)))
Discount Rate = 17.01% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 45.01 | Cagr: 1.46%
[DCF] Terminal Value 55.90% ; FCFF base≈1.55b ; Y1≈1.77b ; Y5≈2.61b
[DCF] Fair Price = 16.04 (EV 15.8b - Net Debt 1.75b = Equity 14.0b / Shares 875.8m; r=16.57% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.00 | EPS CAGR: 31.64% | SUE: 1.32 | # QB: 3
Revenue Correlation: 88.48 | Revenue CAGR: 20.04% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.93 | Chg30d=-0.01% | Revisions=+71% | Analysts=32
EPS next Quarter (2026-10-31): EPS=1.07 | Chg30d=+0.07% | Revisions=+84% | Analysts=30
EPS current Year (2027-01-31): EPS=4.05 | Chg30d=+0.08% | Revisions=+78% | GrowthEPS=+42.6% | GrowthRev=+40.7%
EPS next Year (2028-01-31): EPS=6.20 | Chg30d=+0.43% | Revisions=+73% | GrowthEPS=+53.0% | GrowthRev=+45.0%
[Analyst] Revisions Ratio: +84% (up=95, down=7)